A directory of where to buy chemicals in the UK including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information.
| Product | Description | |
|---|---|---|
| Mitotane Impurities | Mitotane Impurities stand as an indispensable component within the realm of quality control and pharmacokinetic analysis in oncology, particularly concerning adrenocortical carcinoma management. By revealing metabolic pathways, they enhance Mitotane's safety and efficacy, thereby spearheading transformative therapeutic strategies against this challenging malignancy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Mitoxantrone | Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively. It is used in the treatment of certain types of cancer, mostly metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoma. Uses: Analgesics. Group: Pharmaceutical. CAS No. 65271-80-9. Pack Sizes: 2.5 g. Product ID: B2693-074515. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mitoxantrone | 50mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C22H28N4O6. CAS No. 65271-80-9. Prepack ID : 28035650-50mg. Molecular Weight : 444.48. |  |
| Mitoxantrone dihydrochloride | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C22H28N4O6 · 2HCl. CAS No. 70476-82-3. Prepack ID : 24343907-1g. Molecular Weight : 517.4. | |
| Mitoxantrone Impurities | Mitoxantrone Impurities are critical in the quality control and analysis of Mitoxantrone, a chemotherapeutic agent used to treat certain cancers, including leukemia and breast cancer. Understanding these impurities aids in ensuring drug safety and efficacy, promoting advancements in oncological therapies and pharmaceutical research methodologies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mitraphylline | Mitraphylline is an alkaloid isolated from Uncaria rhynchophylla anti-inflammatory activity and inhibiting lipopolysaccharide-mediated activation of primary human neutrophils. Group: Pharmaceutical. CAS No. 509-80-8. Pack Sizes: 5 mg. Product ID: NP0822. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mivebresib | Mivebresib is a BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. Mivebresib is also a MYC and the TMPRSS2-ETS fusion proteins inhibitor. Mivebresib can inhibit cell growth in susceptible tumors. Uses: Anti-tumor. Group: Pharmaceutical. CAS No. 1445993-26-9. Pack Sizes: 300 mg. Product ID: B0084-475449. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mixed Alcohol Solvent ASTM | Mixed alcohol solvent is a clear colourless liquid consisting of butanol and methanol. It has various industrial applications and is commonly used to manufacture products like glue, paint thinner, detergent, and nail polish removers. Mixed alcohol solvent is highly flammable and should be kept away from potential ignition sources. The substance is toxic if it's inhaled or ingested. Anyone who inhales or consumes mixed alcohol solvent should seek medical advice, even if they have no symptoms. Uses: Solvents, laboratory applications. Group: Solvents. Pack Sizes: 2.5L. | Chemicals.co.uk |
| Mizagliflozin | Mizagliflozin is a sodium-glucose transporter inhibitor. It is expected to improve postprandial hyperglycemia by suppressing glucose absorption from the intestine. It blocks intestinal glucose absorption and reduces GIP secretion in rats and humans, which suggests SGLT1 glucose transport is critical for GIP release. It is used for the treatment of diabetes. Group: Pharmaceutical. CAS No. 666843-10-3. Pack Sizes: 10 mg. Product ID: B2693-476096. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-0731 | MK-0731 is a synthetic small molecule with potential antineoplastic activity. MK0731 selectively inhibits kinesin spindle protein (KSP), which may result in the inhibition of mitotic spindle assembly, induction of cell cycle arrest during the mitotic phase, and apoptosis in tumor cells that overexpress KSP. Uses: Potential antineoplastic agent. Group: Pharmaceutical. CAS No. 845256-65-7. Pack Sizes: 5 mg. Product ID: B0084-137625. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-1775 | MK-1775, also known as AZD-1775, is a WEE1 inhibitor and a small-molecule inhibitor of the tyrosine kinase WEE1 with potential antineoplastic sensitizing activity. MK-1775 selectively targets and inhibits WEE1, a tyrosine kinase that phosphorylates cyclin-dependent kinase 1 (CDC2) to inactivate the CDC2/cyclin B complex. Inhibition of WEE1 activity prevents the phosphorylation of CDC2 and impairs the G2 DNA damage checkpoint. This may lead to apoptosis upon treatment with DNA damaging chemotherapeutic agents. Unlike normal cells, most p53-deficient or mutated human cancers lack the G1 checkpoint as p53 is the key regulator of the G1 checkpoint and these cells rely on the G2 checkpoint for DNA repair to damaged cells. Annulment of the G2 checkpoint may therefore make p53-deficient tumor cells more vulnerable to antineoplastic agents and enhance their cytotoxic effect. Group: Pharmaceutical. CAS No. 955365-80-7. Pack Sizes: 300 mg. Product ID: B0084-157422. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-2206 dihydrochloride | MK-2206 is a highly selective Akt inhibitor with IC50 of 8 nM, 12 nM and 65 nM for Akt1, Akt2 and Akt3, respectively. It is undergoing a phase II clinical trial for the treatment of ovarian, fallopian tube, or primary peritoneal cancer where there are mutations in P13K or AKT or low levels of PTEN. Group: Pharmaceutical. CAS No. 1032350-13-2. Pack Sizes: 100 mg. Product ID: B0084-336879. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-4101 | MK-4101 is a potent and selective SMO Inhibitor of the Hedgehog Pathway with anti-tumor activity. MK-4101 targets the Hh pathway in tumor cells, showing the maximum inhibitory effect on Gli1 MK-4101 also induced deregulation of cell cycle and block of DNA replication in tumors. Group: Pharmaceutical. CAS No. 935273-79-3. Pack Sizes: 300 mg. Product ID: B0084-007827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-4827 (R-enantiomer) | MK-4827 (R-enantiomer) is the R form of MK-4827, which is a PARP inhibitor developed for the treatment of ovarian cancer. Group: Pharmaceutical. CAS No. 1038915-58-0. Pack Sizes: 5 mg. Product ID: B0084-138719. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-4827 tosylate | MK-4827 tosylate is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM. It has a great activity in cancer cells with mutant BRCA-1 and BRCA-2, >330-fold selective against PARP3, V-PARP and Tank1. Group: Pharmaceutical. CAS No. 1038915-73-9. Pack Sizes: 100 mg. Product ID: B0084-463500. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-5172 | Grazoprevir is a hepatitis C virus protease inhibitor developed for the treatment of hepatitis C. It suppresses NS3 and NS4A, which play a role in the virus splitting its polyprotein into the functional virus proteins. Grazoprevir is often used in combination with elbasvir or ribavirin. Uses: Antiviral agents. Group: Pharmaceutical. CAS No. 1350514-68-9. Pack Sizes: 100 mg. Product ID: B2693-007134. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-8353 | MK-8353 is an orally available ERK1/2 inhibitor. It exhibited antitumor activity in patients with BRAFV600-mutant melanoma. Group: Pharmaceutical. CAS No. 1184173-73-6. Pack Sizes: 50 mg. Product ID: B2693-291615. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MK-8722 | MK-8722 is a potent pan-AMPK activator that improves glucose homeostasis but induces cardiac hypertrophy. AMPK has long been of interest as a target for the treatment of Type 2 Diabetes Mellitus. Group: Pharmaceutical. CAS No. 1394371-71-1. Pack Sizes: 100 mg. Product ID: B2693-373163. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MKC-3946 | MKC-3946 is a potent inhibitor of inositol-requiring enzyme 1α (IRE1α). It inhibits XBP1 mRNA splicing and exhibits cytotoxicity against AML cells. MKC-3946 leads to modest growth inhibition in MM cells but has no effect on normal mononuclear cells in vitro. Group: Pharmaceutical. CAS No. 1093119-54-0. Pack Sizes: 300 mg. Product ID: B0084-054003. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML204 | ML204 is a novel and potential TRPC4 Channel inhibitor. ML204 inhibited TRPC4β-mediated intracellular Ca(2+) rise with an IC(50) value of 0.96 μm and exhibited 19-fold selectivity against muscarinic receptor-coupled TRPC6 channel activation. Group: Pharmaceutical. CAS No. 5465-86-1. Pack Sizes: 100 mg. Product ID: B0084-470926. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML241 | ML241 is a selective p97 ATPase inhibitor and IC50 value is 100 nM. It can inhibit degradation of a p97-dependent but not a p97-independent proteasome substrate in a dual-reporter cell line. ML241 may be a novel agent for the treatment of cancer. Uses: Anticancer. Group: Pharmaceutical. CAS No. 1346528-06-0. Pack Sizes: 100 mg. Product ID: B0084-475332. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML 297 | ML 297 is a Kir3.1/3.2 (GIRK1/2) channel activator with IC50 values of 160, 887 and 914 nM for GIRK1/2, GIRK1/4 and GIRK1/3. Group: Pharmaceutical. CAS No. 1443246-62-5. Pack Sizes: 100 mg. Product ID: B2693-169428. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML324 | ML324 exhibits good Caco-2 cell permeability, and possesses excellent microsomal stability in the presence of both mouse and rat liver microsomes. Group: Pharmaceutical. CAS No. 1222800-79-4. Pack Sizes: 300 mg. Product ID: B0084-463376. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML 385 | ML 385 is a novel and specific inhibitor of nuclear factor erythroid 2-related factor 2 (Nrf2; IC50 = 1.9 μM). ML 385 blocks NRF2 transcriptional activity, and enhances the efficacy of carboplatin as well as other chemotherapeutic drugs in lung cancer cells (NSCLC). Group: Pharmaceutical. CAS No. 846557-71-9. Pack Sizes: 100 mg. Product ID: B0084-007736. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML390 | ML-390 is an inhibitor of human DHODH, which induces differentiation in acute myeloid leukemia cell lines U937 (murine) and THP-1 (human) cell lines with an EC50 value of approximately 2 μM. Group: Pharmaceutical. CAS No. 2029049-79-2. Pack Sizes: 100 mg. Product ID: B0084-008137. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML 67-33 | ML 67-33 is a K2P potassium channel activator that increases channel currents by activating core gating apparatus of channels. Group: Pharmaceutical. CAS No. 1443290-89-8. Pack Sizes: 25 mg. Product ID: B1370-291155. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MLN0128 | MLN0128, also known as INK128, is a TORC1/2 inhibitor, is also an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. TORC1/2 inhibitor INK128 binds to and inhibits both TORC1 and TORC2 complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some tumors and play an important role in the PI3K/Akt/mTOR signaling pathway, which is frequently dysregulated in human cancers. Group: Pharmaceutical. CAS No. 1224844-38-5. Pack Sizes: 100 mg. Product ID: B2693-453595. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML SA1 | ML SA1 is an activator of TRPML channels. It can induce TRPML-mediated Ca2+ release from lysosomes and reduce cholesterol accumulation in Niemann-Pick type C macrophages. Group: Pharmaceutical. CAS No. 332382-54-4. Pack Sizes: 1 g. Product ID: B2693-169420. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML-SI3 | ML-SI3 is an antagonist of the TRPML family of calcium channels. ML-SI3 can prevent lysosomal calcium efflux and has been reported to block downstream TRPML1-mediated induction of autophagy. Group: Pharmaceutical. CAS No. 891016-02-7. Pack Sizes: 100 mg. Product ID: B1370-330907. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAD | Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload and antibody drug conjugate. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 203849-91-6. Pack Sizes: 10 mg. Product ID: BADC-00309. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAE | Monomethyl Auristatin E (MMAE) is a synthetic analog of dolastatin 10 that similarly inhibits tubulin polymerization and exhibits potent cytotoxicity. It is commonly conjugated with monoclonal antibodies directed at antigens specific to cancer cells for tumor-directed cytotoxicity. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 474645-27-7. Pack Sizes: 25 mg. Product ID: BBF-05782. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAE-[d8] | MMAE-[d8] is a labelled analogue of MMAE, which is a potent mitotic inhibitor and a tubulin inhibitor. Group: Pharmaceutical. CAS No. 2070009-72-0. Pack Sizes: 10 mg. Product ID: BLP-012288. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAF | Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 745017-94-1. Pack Sizes: 10 mg. Product ID: BBF-05779. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| m-Methoxytopolin riboside | It can be used in biological study in influence of plant growth regulators on shoot proliferation and secondary metabolite production in micropropagated Huernia hystrix. Group: Pharmaceutical. CAS No. 101565-95-1. Pack Sizes: 1 g. Product ID: B2706-291769. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| m- Nitro Benzoic Acid | m- Nitro Benzoic Acid, CAS 121-92-6, Performance Chemicals. Formerly Lansdowne Chemicals | OQEMA England, Oxfordshire |
| Moclobemide | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C13H17ClN2O2. CAS No. 71320-77-9. Prepack ID : 68942587-1g. Molecular Weight : 268.74. | |
| Moclobemide | Moclobemide is a reversible monoamine oxidase A (MAO-A) inhibitor, displaying antidepressive activity. Group: Pharmaceutical. CAS No. 71320-77-9. Pack Sizes: 100 mg. Product ID: B0084-075760. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moclobemide Impurities | Moclobemide Impurities play a significant role in quality control and analysis within the pharmaceutical industry, particularly for antidepressant medications. They are critical in ensuring the efficacy and safety of Moclobemide, a monoamine oxidase inhibitor used to treat depression and social anxiety disorder. Analyzing these impurities aids in maintaining drug purity and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Modified Aromatic Hydrocarbon Resin H-Rez -4100 | Hydrocarbon Resins. Adhesive raw materials |  England, Surrey |
| Modified metallic resinates | Modified metallic resinates. Industry Served: Inks |  England |
| Modified rosins | Modified rosins. Industry Served: Adhesives & Sealants, Inks | England |
| Modified tall oil | Modified tall oil. Industry Served: Flotation | England |
| Moexiprilat Impurities | Moexiprilat Impurities, crucial for quality control in pharmaceuticals, are studied to ensure purity in the production of moexipril, an antihypertensive medication. Understanding these impurities aids in refining the synthesis processes, significantly enhancing the safety and efficacy of drugs used to manage hypertension and cardiovascular conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moexipril Impurities | Moexipril Impurities hold a crucial role in the realm of pharmaceutical quality control and investigative studies of Moexipril, a potent antihypertensive agent. By scrutinizing purity, these impurities ensure the drug's safety and efficacy, facilitating advancements in cardiovascular therapeutics and enhancing the development of superior treatment modalities. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mofezolac | Mofezolac is a cyclooxygenase-1 selective inhibitor. Uses: Cyclooxygenase inhibitors. Group: Pharmaceutical. CAS No. 78967-07-4. Pack Sizes: 10 g. Product ID: B2693-008944. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MOG (35-55) | (MOG) 35-55 is a minor component of CNS myelin. Produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. Group: Pharmaceutical. CAS No. 149635-73-4. Pack Sizes: 5 mg. Product ID: BAT-010068. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogrol | Mogrol is a natural compound isolated from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88930-15-8. Pack Sizes: 25 mg. Product ID: NP7047. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IIA2 | Mogroside IIA2 is extracted from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88901-45-5. Pack Sizes: 10 mg. Product ID: B0005-465742. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside III | Mogroside III is extracted from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 130567-83-8. Pack Sizes: 20 mg. Product ID: B0005-465747. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IIIA1 | Mogroside IIIA1 is extracted from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88901-42-2. Pack Sizes: 10 mg. Product ID: B0005-465741. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IIIe | Mogroside IIIe is an exquisite natural compound hailing from Siraitia grosvenorii, revered for its antioxidant prowess. This divine extract aids in studying ailments of oxidative magnitude. Group: Pharmaceutical. CAS No. 88901-37-5. Pack Sizes: 10 mg. Product ID: B0005-465743. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IV | Mogroside IV is extracted from the fruit of Siraitia grosvenorii Swingle. It exhibited maltase inhibitory effect. Group: Pharmaceutical. CAS No. 89590-95-4. Pack Sizes: 10 mg. Product ID: B2703-003393. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IVa | Mogroside IVa is extracted from the fruit of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88901-41-1. Pack Sizes: 10 mg. Product ID: B0005-465739. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside V | Mogroside V is extracted from the fruit of Siraitia grosvenorii Swingle. It is 300 times sweeter than cane sugar and low in calories. It had a significant effect on insulin secretion and confirmed that the natural sweetener LHK could be beneficial for use by diabetic populations. Studies have found that mogrosides V have strong sweetness and functional effects. Group: Pharmaceutical. CAS No. 88901-36-4. Pack Sizes: 20 mg. Product ID: NP7008. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MOISTURE METER WITH | MOISTURE METER WITH, Suppliers of UK laboratory chemicals wanted | |
| MOJAVE YUCCA | MOJAVE YUCCA - Our signature range of liquid botanical extracts |  England, Scotland |
| Molasses | Molasses. At Tan International we supply a wide range of products covering all industry sectors |  Scotland |
| Molekuchine | 5g Pack Size. Group: Bioactive Small Molecules, Biochemicals, Research Organics & Inorganics. Formula: C22H25NO6. CAS No. 64-86-8. Prepack ID : 90023835-5g. Molecular Weight : 399.44. | |
| Molekula Black B | 25g Pack Size. Group: Stains & Indicators. Formula: C29H24N6. CAS No. 4197-25-5. Prepack ID : 21998092-25g. Molecular Weight : 456.54. | |
| Molnupiravir Impurities | Molnupiravir Impurities, indispensable in the realm of biomedical scrutiny, function as critical benchmarks for ascertaining the synthesis fidelity of Molnupiravir. These impurities are central to maintaining the drugs structural integrity and antiviral potency against COVID-19, restraining viral expansion while upholding stringent regulatory and pharmacological standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Molsidomine Impurities | Molsidomine Impurities, prevalent in pharmaceuticals, play a crucial role in quality control and safety during the development of cardiovascular drugs. These impurities are analyzed to ensure the therapeutic efficacy and safety of molsidomine, a drug primarily used to treat angina pectoris by releasing nitric oxide, which dilates blood vessels. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Molybdenum 2-Ethylhexanoate Liquid Mo: 15% | 25g Pack Size. Group: Building Blocks, Organics. Formula: C32H60O8Mo. CAS No. 34041-09-3. Prepack ID : 90028668-25g. Molecular Weight : 668.75. | |
| Molybdenum(IV) sulfide | 100g Pack Size. Group: Analytical Reagents, Catalysts, Inorganic Chemicals, Salts. Formula: MoS2. CAS No. 1317-33-5. Prepack ID : 28269282-100g. Molecular Weight : 160.07. | |
| Molybdenum Trioxide | Molybdenum Trioxide. Uses: Pharmaceuticals, Personal Care, Industrial. Grades: Pharma, Cosmetic, Food, Feed, Technical. CAS No. 1313-27-5. Pack Sizes: Bulk. Cenik is your partner of choice for Hard-to-find chemicals. We don't just provide products, we supply solutions to your technical and regulatory specifications. |  Cenik Chemicals |
| Molybdenum (V) chloride, 99.6% | 25g Pack Size. Group: Inorganic Chemicals, Salts. Formula: Cl5Mo. CAS No. 10241-05-1. Prepack ID : 24369259-25g. Molecular Weight : 273.21. | |
| Molybdenum(VI) oxide | 25g Pack Size. Group: Building Blocks, Inorganic Chemicals. Formula: MoO3. CAS No. 1313-27-5. Prepack ID : 32376934-25g. Molecular Weight : 143.94. | |
| Molybdic acid | 100g Pack Size. Group: Inorganic Chemicals, Research Organics & Inorganics. Formula: H2MoO4. CAS No. 7782-91-4. Prepack ID : 16464487-100g. Molecular Weight : 161.95. | |
| Mometasone Furoate | Mometasone furoate, prodrug of the free form mometasone, is an agent with high affinity for the glucocorticoid receptor with anti-allergic property. It can be used to treat asthma and allergic rhinitis. Uses: The treatment of asthma and allergic rhinitis. Group: Pharmaceutical. CAS No. 83919-23-7. Pack Sizes: 5 g. Product ID: B0084-078204. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mometasone Furoate EP Impurity D | An impurity of Mometasone furoate, which is a topical corticosteroid used as an anti-inflammatory. Group: Pharmaceutical. CAS No. 83881-09-8. Pack Sizes: 100 mg. Product ID: B1370-477792. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mometasone Furoate EP Impurity E | An impurity of Mometasone furoate, which is a topical corticosteroid used as an anti-inflammatory. Group: Pharmaceutical. CAS No. 1370190-33-2. Pack Sizes: 100 mg. Product ID: B1370-477795. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
